Skip to main content
NCBI home page
Gut logoLink to Gut
. 1996 May;38(5):646–648. doi: 10.1136/gut.38.5.646

Non-steroidal anti-inflammatory drugs and the chemoprevention of colorectal and oesophageal cancers.

G Morgan 1
PMCID: PMC1383142  PMID: 8707106

Full text

PDF
646

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Botha J. H., Robinson K. M., Ramchurren N., Reddi K., Norman R. J. Human esophageal carcinoma cell lines: prostaglandin production, biological properties, and behavior in nude mice. J Natl Cancer Inst. 1986 Jun;76(6):1053–1056. [PubMed] [Google Scholar]
  2. Cauvin J. M., Goldfain D., Le Rhun M., Robaszkiewicz M., Cadiot G., Carpentier S., Rotenberg A., Mignon M., Boyer J., Galmiche J. P. Multicentre prospective controlled study of Barrett's oesophagus and colorectal adenomas. Groupe d'Etude de l'Oesophage de Barrett. Lancet. 1995 Nov 25;346(8987):1391–1394. doi: 10.1016/s0140-6736(95)92406-x. [DOI] [PubMed] [Google Scholar]
  3. Craven P. A., DeRubertis F. R. Effects of aspirin on 1,2-dimethylhydrazine-induced colonic carcinogenesis. Carcinogenesis. 1992 Apr;13(4):541–546. doi: 10.1093/carcin/13.4.541. [DOI] [PubMed] [Google Scholar]
  4. Eberhart C. E., Coffey R. J., Radhika A., Giardiello F. M., Ferrenbach S., DuBois R. N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 1994 Oct;107(4):1183–1188. doi: 10.1016/0016-5085(94)90246-1. [DOI] [PubMed] [Google Scholar]
  5. Fries J. F., Ramey D. R., Singh G., Morfeld D., Bloch D. A., Raynauld J. P. A reevaluation of aspirin therapy in rheumatoid arthritis. Arch Intern Med. 1993 Nov 8;153(21):2465–2471. [PubMed] [Google Scholar]
  6. Funkhouser E. M., Sharp G. B. Aspirin and reduced risk of esophageal carcinoma. Cancer. 1995 Oct 1;76(7):1116–1119. doi: 10.1002/1097-0142(19951001)76:7<1116::aid-cncr2820760703>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  7. Giardiello F. M., Hamilton S. R., Krush A. J., Piantadosi S., Hylind L. M., Celano P., Booker S. V., Robinson C. R., Offerhaus G. J. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med. 1993 May 6;328(18):1313–1316. doi: 10.1056/NEJM199305063281805. [DOI] [PubMed] [Google Scholar]
  8. Giovannucci E., Rimm E. B., Stampfer M. J., Colditz G. A., Ascherio A., Willett W. C. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med. 1994 Aug 15;121(4):241–246. doi: 10.7326/0003-4819-121-4-199408150-00001. [DOI] [PubMed] [Google Scholar]
  9. Gore S., Healey C. J., Sutton R., Eyre-Brook I. A., Gear M. W., Shepherd N. A., Wilkinson S. P. Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy. Aliment Pharmacol Ther. 1993 Dec;7(6):623–628. doi: 10.1111/j.1365-2036.1993.tb00143.x. [DOI] [PubMed] [Google Scholar]
  10. Greenberg E. R., Baron J. A., Freeman D. H., Jr, Mandel J. S., Haile R. Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study Group. J Natl Cancer Inst. 1993 Jun 2;85(11):912–916. doi: 10.1093/jnci/85.11.912. [DOI] [PubMed] [Google Scholar]
  11. Heath C. W., Jr, Thun M. J., Greenberg E. R., Levin B., Marnett L. J. Nonsteroidal antiinflammatory drugs and human cancer. Report of an interdisciplinary research workshop. Cancer. 1994 Nov 15;74(10):2885–2888. doi: 10.1002/1097-0142(19941115)74:10<2885::aid-cncr2820741023>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  12. Heller S. R., Fellows I. W., Ogilvie A. L., Atkinson M. Non-steroidal anti-inflammatory drugs and benign oesophageal stricture. Br Med J (Clin Res Ed) 1982 Jul 17;285(6336):167–168. doi: 10.1136/bmj.285.6336.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kaufmann H. J., Taubin H. L. Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease. Ann Intern Med. 1987 Oct;107(4):513–516. doi: 10.7326/0003-4819-107-4-513. [DOI] [PubMed] [Google Scholar]
  14. Kudo T., Narisawa T., Abo S. Antitumor activity of indomethacin on methylazoxymethanol-induced large bowel tumors in rats. Gan. 1980 Apr;71(2):260–264. [PubMed] [Google Scholar]
  15. Kune G. A., Kune S., Watson L. F. Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res. 1988 Aug 1;48(15):4399–4404. [PubMed] [Google Scholar]
  16. Labayle D., Fischer D., Vielh P., Drouhin F., Pariente A., Bories C., Duhamel O., Trousset M., Attali P. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology. 1991 Sep;101(3):635–639. doi: 10.1016/0016-5085(91)90519-q. [DOI] [PubMed] [Google Scholar]
  17. Logan R. F., Little J., Hawtin P. G., Hardcastle J. D. Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme. BMJ. 1993 Jul 31;307(6899):285–289. doi: 10.1136/bmj.307.6899.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Morgan G. P. Aspirin and the risk of digestive cancers. Arch Intern Med. 1995 Jan 23;155(2):213-4, 217. [PubMed] [Google Scholar]
  19. Morgan G. P., Williams J. G. Inflammatory mediators in the oesophagus. Gut. 1994 Mar;35(3):297–298. doi: 10.1136/gut.35.3.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Morgan G. P., Williams J. G. Therapeutic potential of aspirin in cancer of the colon. BMJ. 1993 Oct 16;307(6910):1007–1008. doi: 10.1136/bmj.307.6910.1007-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Muscat J. E., Stellman S. D., Wynder E. L. Nonsteroidal antiinflammatory drugs and colorectal cancer. Cancer. 1994 Oct 1;74(7):1847–1854. doi: 10.1002/1097-0142(19941001)74:7<1847::aid-cncr2820740704>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  22. Oka M., Attwood S. E., Kaul B., Smyrk T. C., DeMeester T. R. Immunosuppression in patients with Barrett's esophagus. Surgery. 1992 Jul;112(1):11–17. [PubMed] [Google Scholar]
  23. Peleg I. I., Maibach H. T., Brown S. H., Wilcox C. M. Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer. Arch Intern Med. 1994 Feb 28;154(4):394–399. [PubMed] [Google Scholar]
  24. Pollard M., Luckert P. H. Effect of piroxicam on primary intestinal tumors induced in rats by N-methylnitrosourea. Cancer Lett. 1984 Dec;25(2):117–121. doi: 10.1016/s0304-3835(84)80035-x. [DOI] [PubMed] [Google Scholar]
  25. Pollard M., Luckert P. H. Indomethacin treatment of rats with dimethylhydrazine-induced intestinal tumors. Cancer Treat Rep. 1980;64(12):1323–1327. [PubMed] [Google Scholar]
  26. Pugh S., Thomas G. A. Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2. Gut. 1994 May;35(5):675–678. doi: 10.1136/gut.35.5.675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Rosenberg L., Palmer J. R., Zauber A. G., Warshauer M. E., Stolley P. D., Shapiro S. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst. 1991 Mar 6;83(5):355–358. doi: 10.1093/jnci/83.5.355. [DOI] [PubMed] [Google Scholar]
  28. Rubio C. A. Further studies on the therapeutic effect of indomethacin on esophageal tumors. Cancer. 1986 Sep 1;58(5):1029–1031. doi: 10.1002/1097-0142(19860901)58:5<1029::aid-cncr2820580508>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  29. Rubio C. A., Wallin B., Ware J., Sveander M., Duvander A. Effect of indomethacin in autotransplanted colonic tumors. Dis Colon Rectum. 1989 Jun;32(6):488–491. doi: 10.1007/BF02554503. [DOI] [PubMed] [Google Scholar]
  30. Scheiman J. M., Behler E. M., Loeffler K. M., Elta G. H. Omeprazole ameliorates aspirin-induced gastroduodenal injury. Dig Dis Sci. 1994 Jan;39(1):97–103. doi: 10.1007/BF02090067. [DOI] [PubMed] [Google Scholar]
  31. Schreinemachers D. M., Everson R. B. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology. 1994 Mar;5(2):138–146. doi: 10.1097/00001648-199403000-00003. [DOI] [PubMed] [Google Scholar]
  32. Stein H. J., Barlow A. P., DeMeester T. R., Hinder R. A. Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux. Ann Surg. 1992 Jul;216(1):35–43. doi: 10.1097/00000658-199207000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Suh O., Mettlin C., Petrelli N. J. Aspirin use, cancer, and polyps of the large bowel. Cancer. 1993 Aug 15;72(4):1171–1177. doi: 10.1002/1097-0142(19930815)72:4<1171::aid-cncr2820720407>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  34. Taha A. S., Dahill S., Sturrock R. D., Lee F. D., Russell R. I. Predicting NSAID related ulcers--assessment of clinical and pathological risk factors and importance of differences in NSAID. Gut. 1994 Jul;35(7):891–895. doi: 10.1136/gut.35.7.891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Thun M. J., Namboodiri M. M., Calle E. E., Flanders W. D., Heath C. W., Jr Aspirin use and risk of fatal cancer. Cancer Res. 1993 Mar 15;53(6):1322–1327. [PubMed] [Google Scholar]
  36. Thun M. J., Namboodiri M. M., Heath C. W., Jr Aspirin use and reduced risk of fatal colon cancer. N Engl J Med. 1991 Dec 5;325(23):1593–1596. doi: 10.1056/NEJM199112053252301. [DOI] [PubMed] [Google Scholar]
  37. Waddell W. R., Ganser G. F., Cerise E. J., Loughry R. W. Sulindac for polyposis of the colon. Am J Surg. 1989 Jan;157(1):175–179. doi: 10.1016/0002-9610(89)90442-x. [DOI] [PubMed] [Google Scholar]
  38. Waddell W. R., Loughry R. W. Sulindac for polyposis of the colon. J Surg Oncol. 1983 Sep;24(1):83–87. doi: 10.1002/jso.2930240119. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES